Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems,
Toshiba's nuclear medicine division is adding enhancements to its line of gamma cameras.The Tustin, CA, vendor is planning to extend its transmission-emissionartifact-correction technique from its triple-head gamma camerasto its dual-head systems, according to Steve Sickels, divisionmanager.
Toshiba displayed transmission-emission attenuation correctionas a work-in-progress at last year's Radiological Society of NorthAmerica meeting. The technique was shown on Toshiba's triple-headGCA-9300A camera, but Toshiba also has an active R&D programin Japan to bring the technology to the dual-head GCA-7200A, accordingto Sickels. The dual-head version, which is also a work-in-progress,will involve a combination of a stationary line source of radioactivityand collimation, he said. GCA-7200A is an opposable dual-headcamera.
Toshiba also has a program in the works to develop 511-keVcollimators for SPECT imaging with fluorodeoxyglucose (FDG), Sickelssaid.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
March 8th 2025The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.